Anna Bobenko
Overview
Explore the profile of Anna Bobenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mueller S, Winzer E, Duvinage A, Gevaert A, Edelmann F, Haller B, et al.
JAMA
. 2021 Feb;
325(6):542-551.
PMID: 33560320
Importance: Endurance exercise is effective in improving peak oxygen consumption (peak V̇o2) in patients with heart failure with preserved ejection fraction (HFpEF). However, it remains unknown whether differing modes of...
2.
Bobenko A, Duvinage A, Mende M, Holzendorf V, Nolte K, Herrmann-Lingen C, et al.
Int J Cardiol Heart Vasc
. 2020 May;
28:100525.
PMID: 32420447
Aims: High prevalence and lack of pharmacological treatment are making heart failure with preserved ejection fraction (HFpEF) a growing public health problem. No algorithm for the screening of asymptomatic patients...
3.
Bobenko A, Schoenrath F, Knierim J, Friede T, Verheyen N, Mehra M, et al.
Eur J Heart Fail
. 2019 Mar;
21(9):1152-1159.
PMID: 30924265
Aims: Left ventricular assist device (LVAD) therapy is a promising option for patients with advanced heart failure (HF), refractory to guideline-mandated medical treatment either as a bridge to heart transplantation...
4.
Belyavskiy E, Morris D, Url-Michitsch M, Verheyen N, Meinitzer A, Radhakrishnan A, et al.
ESC Heart Fail
. 2018 Nov;
6(1):146-153.
PMID: 30451399
Aims: The purpose of this pilot study was to assess the potential usefulness of diastolic stress test (DST) echocardiography in patients with suspected heart failure with preserved ejection fraction (HFpEF)....
5.
Bobenko A, Bartels I, Munch M, Trippel T, Lindhorst R, Nolte K, et al.
ESC Heart Fail
. 2017 Dec;
5(1):53-62.
PMID: 29210202
Aims: Heart failure with preserved ejection fraction (HFpEF) remains a common condition with no pharmacological treatment. Physical activity (PA) improves symptoms and quality of life (QoL), but no clear recommendations...
6.
Trippel T, Van Linthout S, Westermann D, Lindhorst R, Sandek A, Ernst S, et al.
Eur J Heart Fail
. 2017 Sep;
20(3):460-470.
PMID: 28891228
Aim: Heart failure with preserved ejection fraction (HFpEF) is associated with myocardial remodelling including severe pro-fibrotic changes contributing to an increase in left ventricular stiffness and diastolic dysfunction. Serum C-terminal...
7.
Edelmann F, Bobenko A, Gelbrich G, Hasenfuss G, Herrmann-Lingen C, Duvinage A, et al.
Eur J Heart Fail
. 2017 May;
19(8):1067-1074.
PMID: 28516519
Heart failure with preserved ejection fraction (HFpEF) is a common disease with high incidence and increasing prevalence. Patients suffer from functional limitation, poor health-related quality of life, and reduced prognosis....
8.
Luers C, Trippel T, Seelander S, Wachter R, Hasenfuss G, Lindhorst R, et al.
J Am Soc Hypertens
. 2017 Apr;
11(5):303-313.
PMID: 28411073
Left ventricular filling pressure (LVFP) is a marker for diastolic dysfunction and heart failure (HF) with preserved ejection fraction (pEF). The interaction between arterial stiffness (AS) and elevated LVFP has...